Q BioMed QBIO Stock
Q BioMed Price Chart
Q BioMed QBIO Financial and Trading Overview
| Q BioMed stock price | 0.0001 USD |
| Previous Close | 0.008 USD |
| Open | 0.008 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0079 - 0.009 USD |
| 52 Week Range | 0.005 - 0.22 USD |
| Volume | 618.78K USD |
| Avg. Volume | 425.26K USD |
| Market Cap | 1.14M USD |
| Beta (5Y Monthly) | 2.216901 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6 USD |
QBIO Valuation Measures
| Enterprise Value | 10.3M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.043888886 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.0033126 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 36.217 |
| Enterprise Value/EBITDA | -3.033 |
Trading Information
Q BioMed Stock Price History
| Beta (5Y Monthly) | 2.216901 |
| 52-Week Change | -88.88% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.22 USD |
| 52 Week Low | 0.005 USD |
| 50-Day Moving Average | 0.01 USD |
| 200-Day Moving Average | 0.01 USD |
QBIO Share Statistics
| Avg. Volume (3 month) | 425.26K USD |
| Avg. Daily Volume (10-Days) | 325.15K USD |
| Shares Outstanding | 144.1M |
| Float | 139.91M |
| Short Ratio | N/A |
| % Held by Insiders | 8.07% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 2499:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | November 30, 2022 |
| Most Recent Quarter (mrq) | November 30, 2022 |
| Next Fiscal Year End | November 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1211.74% |
| Gross Margin | -3.16% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -99.58% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 284.35K USD |
| Revenue Per Share (ttm) | 0.006 USD |
| Quarterly Revenue Growth (yoy) | -88.099% |
| Gross Profit (ttm) | -8988 USD |
| EBITDA | -3395615 USD |
| Net Income Avi to Common (ttm) | -3494084 USD |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 49.97K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 4.11M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.009 |
| Book Value Per Share (mrq) | -0.115 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.94M USD |
| Levered Free Cash Flow (ttm) | 531.9K USD |
Profile of Q BioMed
| Country | United States |
| State | NY |
| City | New York |
| Address | 366 Madison Avenue |
| ZIP | 10017 |
| Phone | 212-588-0022 |
| Website | https://www.qbiomed.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride Sr-89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, that is used for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B, a novel chemotherapeutic for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutic drugs to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.
Q&A For Q BioMed Stock
What is a current QBIO stock price?
Q BioMed QBIO stock price today per share is 0.0001 USD.
How to purchase Q BioMed stock?
You can buy QBIO shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Q BioMed?
The stock symbol or ticker of Q BioMed is QBIO.
Which industry does the Q BioMed company belong to?
The Q BioMed industry is Biotechnology.
How many shares does Q BioMed have in circulation?
The max supply of Q BioMed shares is 145.09M.
What is Q BioMed Price to Earnings Ratio (PE Ratio)?
Q BioMed PE Ratio is now.
What was Q BioMed earnings per share over the trailing 12 months (TTM)?
Q BioMed EPS is -0.02 USD over the trailing 12 months.
Which sector does the Q BioMed company belong to?
The Q BioMed sector is Healthcare.